Aktaş, B.Y.; Ata, E.B.; Çeşmeci, E.; Çakır, İ.Y.; Coşkunpınar, M.; Tahillioğlu, Y.; Güner, G.; Güven, D.C.; Arık, Z.; Kertmen, N.;
et al. Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia. Curr. Oncol. 2023, 30, 9689-9700.
https://doi.org/10.3390/curroncol30110703
AMA Style
Aktaş BY, Ata EB, Çeşmeci E, Çakır İY, Coşkunpınar M, Tahillioğlu Y, Güner G, Güven DC, Arık Z, Kertmen N,
et al. Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia. Current Oncology. 2023; 30(11):9689-9700.
https://doi.org/10.3390/curroncol30110703
Chicago/Turabian Style
Aktaş, Burak Yasin, Emine Büşra Ata, Engin Çeşmeci, İbrahim Yahya Çakır, Muharrem Coşkunpınar, Yağmur Tahillioğlu, Gürkan Güner, Deniz Can Güven, Zafer Arık, Neyran Kertmen,
and et al. 2023. "Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia" Current Oncology 30, no. 11: 9689-9700.
https://doi.org/10.3390/curroncol30110703
APA Style
Aktaş, B. Y., Ata, E. B., Çeşmeci, E., Çakır, İ. Y., Coşkunpınar, M., Tahillioğlu, Y., Güner, G., Güven, D. C., Arık, Z., Kertmen, N., Dizdar, Ö., Yalçın, Ş., & Aksoy, S.
(2023). Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia. Current Oncology, 30(11), 9689-9700.
https://doi.org/10.3390/curroncol30110703
